Clinical significance of serum hyaluronan levels in systemic sclerosis: Association with disease severity

Ayumi Yoshizaki, Yohei Iwata, Kazuhiro Komura, Toshihide Hara, Fumihide Ogawa, Eiji Muroi, Motoi Takenaka, Kazuhiro Shimizu, Minoru Hasegawa, Manabu Fujimoto, Shinichi Sato

研究成果: Article査読

24 被引用数 (Scopus)

抄録

Objective. To determine any clinical association of serum levels of hyaluronan in patients with systemic sclerosis (SSc). Methods. Hyaluronan levels in serum samples from patients with SSc (n = 66) and hyaluronan expression in skin were assessed. Results. Serum hyaluronan levels in SSc patients were higher than those in healthy controls. SSc patients with elevated hyaluronan levels had more frequent involvement of several clinical manifestations and immunological abnormalities compared to those with normal levels. Thus, hyaluronan levels correlated with disease severity. Hyaluronan expression in the sclerotic skin from SSc patients was more intense, relative to expression in normal skin. Conclusion. These results suggest that elevated serum hyaluronan levels are associated with disease severity and immunological abnormalities in patients with SSc. The Journal of Rheumatology

本文言語English
ページ(範囲)1825-1829
ページ数5
ジャーナルJournal of Rheumatology
35
9
出版ステータスPublished - 09-2008
外部発表はい

All Science Journal Classification (ASJC) codes

  • リウマチ学
  • 免疫アレルギー学
  • 免疫学

フィンガープリント

「Clinical significance of serum hyaluronan levels in systemic sclerosis: Association with disease severity」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル